ID   PTGDS_HUMAN             Reviewed;         190 AA.
AC   P41222; B2R727; Q5SQ10; Q7M4P3; Q9UC22; Q9UCC9; Q9UCD9;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 1.
DT   10-MAY-2017, entry version 173.
DE   RecName: Full=Prostaglandin-H2 D-isomerase;
DE            EC=5.3.99.2;
DE   AltName: Full=Beta-trace protein;
DE   AltName: Full=Cerebrin-28;
DE   AltName: Full=Glutathione-independent PGD synthase;
DE   AltName: Full=Lipocalin-type prostaglandin-D synthase;
DE   AltName: Full=Prostaglandin-D2 synthase;
DE            Short=PGD2 synthase;
DE            Short=PGDS;
DE            Short=PGDS2;
DE   Flags: Precursor;
GN   Name=PTGDS; Synonyms=PDS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=1902577; DOI=10.1073/pnas.88.9.4020;
RA   Nagata A., Suzuki Y., Igarashi M., Eguchi N., Toh H., Urade Y.,
RA   Hayaishi O.;
RT   "Human brain prostaglandin D synthase has been evolutionarily
RT   differentiated from lipophilic-ligand carrier proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:4020-4024(1991).
RN   [2]
RP   SEQUENCE REVISION TO 12; 16; 19; 36; 56; 73; 77; 99; 100; 127 AND 176.
RA   Nagata A., Suzuki Y., Igarashi M., Eguchi N., Toh H., Urade Y.,
RA   Hayaishi O.;
RL   Submitted (AUG-2006) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Brain;
RX   PubMed=1385416;
RA   White D.M., Mikol D.D., Espinosa R., Weimer B., le Beau M.M.,
RA   Stefansson K.;
RT   "Structure and chromosomal localization of the human gene for a brain
RT   form of prostaglandin D2 synthase.";
RL   J. Biol. Chem. 267:23202-23208(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Testis;
RA   Lu J.C., Li X.Y., Huang Y.F., Zhang X.R.;
RT   "cDNA cloning and sequence analysis of prostaglandin D synthase in
RT   human testis.";
RL   (In) Robaire B., Chemes H., Morales C.R. (eds.);
RL   Andrology in the 21st century, pp.189-193, Medimond Publishing Company
RL   Inc., Englewood (2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (NOV-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   PROTEIN SEQUENCE OF 23-190, AND GLYCOSYLATION AT ASN-51 AND ASN-78.
RC   TISSUE=Cerebrospinal fluid;
RX   PubMed=8336134;
RA   Hoffmann A., Conradt H.S., Gross G., Nimtz M., Lottspeich F.,
RA   Wurster U.;
RT   "Purification and chemical characterization of beta-trace protein from
RT   human cerebrospinal fluid: its identification as prostaglandin D
RT   synthase.";
RL   J. Neurochem. 61:451-456(1993).
RN   [13]
RP   PROTEIN SEQUENCE OF 23-37; 67-77; 117-126 AND 169-178, TISSUE
RP   SPECIFICITY, AND GLYCOSYLATION.
RC   TISSUE=Cerebrospinal fluid;
RX   PubMed=7692978;
RA   Harrington M.G., Aebersold R., Martin B.M., Merril C.R., Hood L.;
RT   "Identification of a brain-specific human cerebrospinal fluid
RT   glycoprotein, beta-trace protein.";
RL   Appl. Theor. Electrophor. 3:229-234(1993).
RN   [14]
RP   PROTEIN SEQUENCE OF 23-50.
RC   TISSUE=Cerebrospinal fluid;
RX   PubMed=7689714; DOI=10.1016/0304-3940(93)90179-O;
RA   Zahn M., Maeder M., Schmidt B., Bollensen E., Felgenhauer K.;
RT   "Purification and N-terminal sequence of beta-trace, a protein
RT   abundant in human cerebrospinal fluid.";
RL   Neurosci. Lett. 154:93-95(1993).
RN   [15]
RP   PROTEIN SEQUENCE OF 23-41.
RC   TISSUE=Cerebrospinal fluid;
RX   PubMed=1726844; DOI=10.1016/0006-8993(91)91666-O;
RA   Kuruvilla A.P., Hochwald G.M., Ghiso J., Castano E.M., Pizzolato M.,
RA   Frangione B.;
RT   "Isolation and amino terminal sequence of beta-trace, a novel protein
RT   from human cerebrospinal fluid.";
RL   Brain Res. 565:337-340(1991).
RN   [16]
RP   PROTEIN SEQUENCE OF 23-38, FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Seminal plasma;
RX   PubMed=9475419; DOI=10.1095/biolreprod58.2.600;
RA   Tokugawa Y., Kunishige I., Kubota Y., Shimoya K., Nobunaga T.,
RA   Kimura T., Saji F., Murata Y., Eguchi N., Oda H., Urade Y.,
RA   Hayaishi O.;
RT   "Lipocalin-type prostaglandin D synthase in human male reproductive
RT   organs and seminal plasma.";
RL   Biol. Reprod. 58:600-607(1998).
RN   [17]
RP   PROTEIN SEQUENCE OF 23-35, TISSUE SPECIFICITY, AND USE AS A MARKER FOR
RP   BRAIN TUMOR.
RX   PubMed=9844724;
RA   Saso L., Leone M.G., Sorrentino C., Giacomelli S., Silvestrini B.,
RA   Grima J., Li J.C.H., Samy E., Mruk D., Cheng C.Y.;
RT   "Quantification of prostaglandin D synthetase in cerebrospinal fluid:
RT   a potential marker for brain tumor.";
RL   Biochem. Mol. Biol. Int. 46:643-656(1998).
RN   [18]
RP   PROTEIN SEQUENCE OF 23-34.
RC   TISSUE=Cerebrospinal fluid;
RX   PubMed=8336140;
RA   Leone M.G., Saso L., Del Vecchio A., Mo M., Silvestrini B.,
RA   Cheng C.Y.;
RT   "Micropurification of two human cerebrospinal fluid proteins by high
RT   performance electrophoresis chromatography.";
RL   J. Neurochem. 61:533-540(1993).
RN   [19]
RP   PROTEIN SEQUENCE OF 30-44, DEVELOPMENTAL STAGE, AND EXPRESSION IN
RP   ABNORMAL PREGNANCIES.
RC   TISSUE=Amniotic fluid;
RX   PubMed=8674187;
RA   Melegos D.N., Yu H., Diamandis E.P.;
RT   "Prostaglandin D2 synthase: a component of human amniotic fluid and
RT   its association with fetal abnormalities.";
RL   Clin. Chem. 42:1042-1050(1996).
RN   [20]
RP   PROTEIN SEQUENCE OF 58-73 AND 123-140, AND TISSUE SPECIFICITY.
RC   TISSUE=Cerebrospinal fluid;
RX   PubMed=8599604; DOI=10.1016/0167-4889(95)00182-4;
RA   Giacomelli S., Leone M.-G., Grima J., Silvestrini B., Cheng C.Y.;
RT   "Astrocytes synthesize and secrete prostaglandin D synthetase in
RT   vitro.";
RL   Biochim. Biophys. Acta 1310:269-276(1996).
RN   [21]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND USE AS A MARKER FOR
RP   MENINGIOMA.
RX   PubMed=9065498;
RA   Yamashima T., Sakuda K., Tohma Y., Yamashita J., Oda H., Irikura D.,
RA   Eguchi N., Beuckmann C.T., Kanaoka Y., Urade Y., Hayaishi O.;
RT   "Prostaglandin D synthase (beta-trace) in human arachnoid and
RT   meningioma cells: roles as a cell marker or in cerebrospinal fluid
RT   absorption, tumorigenesis, and calcification process.";
RL   J. Neurosci. 17:2376-2382(1997).
RN   [22]
RP   TISSUE SPECIFICITY.
RX   PubMed=8761996; DOI=10.1016/0304-3940(96)12614-8;
RA   Bloedorn B., Maeder M., Urade Y., Hayaishi O., Felgenhauer K.,
RA   Brueck W.;
RT   "Choroid plexus: the major site of mRNA expression for the beta-trace
RT   protein (prostaglandin D synthase) in human brain.";
RL   Neurosci. Lett. 209:117-120(1996).
RN   [23]
RP   TISSUE SPECIFICITY.
RX   PubMed=9405674; DOI=10.1073/pnas.94.26.14689;
RA   Eguchi Y., Eguchi N., Oda H., Seiki K., Kijima Y., Matsu-ura Y.,
RA   Urade Y., Hayaishi O.;
RT   "Expression of lipocalin-type prostaglandin D synthase (beta-trace) in
RT   human heart and its accumulation in the coronary circulation of angina
RT   patients.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:14689-14694(1997).
RN   [24]
RP   TISSUE SPECIFICITY.
RX   PubMed=10462696;
RX   DOI=10.1002/(SICI)1097-4547(19990901)57:5<730::AID-JNR14>3.0.CO;2-7;
RA   Bloedorn B., Brueck W., Tumani H., Michel U., Rieckmann P.,
RA   Althans N., Maeder M.;
RT   "Expression of the beta-trace protein in human pachymeninx as revealed
RT   by in situ hybridization and immunocytochemistry.";
RL   J. Neurosci. Res. 57:730-734(1999).
RN   [25]
RP   TISSUE SPECIFICITY, AND USE AS A MARKER FOR RENAL INJURY IN
RP   HYPERTENSION.
RX   PubMed=11882588; DOI=10.1161/hy0202.102835;
RA   Hirawa N., Uehara Y., Yamakado M., Toya Y., Gomi T., Ikeda T.,
RA   Eguchi Y., Takagi M., Oda H., Seiki K., Urade Y., Umemura S.;
RT   "Lipocalin-type prostaglandin D synthase in essential hypertension.";
RL   Hypertension 39:449-454(2002).
RN   [26]
RP   INDUCTION BY THYROID HORMONE.
RX   PubMed=9162076; DOI=10.1074/jbc.272.22.14387;
RA   White D.M., Takeda T., DeGroot L.J., Stefansson K., Arnason B.G.W.;
RT   "Beta-trace gene expression is regulated by a core promoter and a
RT   distal thyroid hormone response element.";
RL   J. Biol. Chem. 272:14387-14393(1997).
RN   [27]
RP   USE AS A MARKER FOR NEUROLOGICAL DISORDERS.
RX   PubMed=11669522;
RX   DOI=10.1002/1522-2683(200109)22:16<3433::AID-ELPS3433>3.0.CO;2-Y;
RA   Hiraoka A., Seiki K., Oda H., Eguchi N., Urade Y., Tominaga I.,
RA   Baba K.;
RT   "Charge microheterogeneity of the beta-trace proteins (lipocalin-type
RT   prostaglandin D synthase) in the cerebrospinal fluid of patients with
RT   neurological disorders analyzed by capillary isoelectrofocusing.";
RL   Electrophoresis 22:3433-3437(2001).
RN   [28]
RP   USE AS A MARKER FOR RENAL INJURY IN DIABETES MELLITUS.
RX   PubMed=11287775; DOI=10.1159/000045937;
RA   Hirawa N., Uehara Y., Ikeda T., Gomi T., Hamano K., Totsuka Y.,
RA   Yamakado M., Takagi M., Eguchi N., Oda H., Seiki K., Nakajima H.,
RA   Urade Y.;
RT   "Urinary prostaglandin D synthase (beta-trace) excretion increases in
RT   the early stage of diabetes mellitus.";
RL   Nephron 87:321-327(2001).
RN   [29]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-78.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [30]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-51.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [31]
RP   GLYCOSYLATION AT ASN-78.
RX   PubMed=19139490; DOI=10.1074/mcp.M800504-MCP200;
RA   Jia W., Lu Z., Fu Y., Wang H.P., Wang L.H., Chi H., Yuan Z.F.,
RA   Zheng Z.B., Song L.N., Han H.H., Liang Y.M., Wang J.L., Cai Y.,
RA   Zhang Y.K., Deng Y.L., Ying W.T., He S.M., Qian X.H.;
RT   "A strategy for precise and large scale identification of core
RT   fucosylated glycoproteins.";
RL   Mol. Cell. Proteomics 8:913-923(2009).
RN   [32]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-51 AND ASN-78, AND
RP   STRUCTURE OF CARBOHYDRATES.
RC   TISSUE=Cerebrospinal fluid;
RX   PubMed=19838169; DOI=10.1038/nmeth.1392;
RA   Nilsson J., Rueetschi U., Halim A., Hesse C., Carlsohn E.,
RA   Brinkmalm G., Larson G.;
RT   "Enrichment of glycopeptides for glycan structure and attachment site
RT   identification.";
RL   Nat. Methods 6:809-811(2009).
RN   [33]
RP   GLYCOSYLATION AT ASN-78, STRUCTURE OF CARBOHYDRATES, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=22171320; DOI=10.1074/mcp.M111.013649;
RA   Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.;
RT   "Human urinary glycoproteomics; attachment site specific analysis of
RT   N-and O-linked glycosylations by CID and ECD.";
RL   Mol. Cell. Proteomics 0:0-0(2011).
RN   [34]
RP   GLYCOSYLATION AT SER-29, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=23234360; DOI=10.1021/pr300963h;
RA   Halim A., Ruetschi U., Larson G., Nilsson J.;
RT   "LC-MS/MS characterization of O-glycosylation sites and glycan
RT   structures of human cerebrospinal fluid glycoproteins.";
RL   J. Proteome Res. 12:573-584(2013).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 29-190 OF MUTANT ALA-65 IN
RP   COMPLEXES WITH FATTY ACIDS, FUNCTION, CATALYTIC ACTIVITY, SUBUNIT,
RP   MUTAGENESIS OF LYS-59; MET-64; CYS-65; LEU-79; PHE-83; LEU-131 AND
RP   TYR-149, AND DOMAIN.
RX   PubMed=20667974; DOI=10.1096/fj.10-164863;
RA   Zhou Y., Shaw N., Li Y., Zhao Y., Zhang R., Liu Z.J.;
RT   "Structure-function analysis of human l-prostaglandin D synthase bound
RT   with fatty acid molecules.";
RL   FASEB J. 24:4668-4677(2010).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 23-190 IN COMPLEX WITH
RP   SUBSTRATE ANALOG.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of the human lipocalin-type prostaglandin D
RT   synthase crystallised with the substrate analog 9,11-dideoxy-
RT   9alpha,11alpha- epoxymethanoprostaglandin f2alpha.";
RL   Submitted (JAN-2010) to the PDB data bank.
CC   -!- FUNCTION: Catalyzes the conversion of PGH2 to PGD2, a
CC       prostaglandin involved in smooth muscle contraction/relaxation and
CC       a potent inhibitor of platelet aggregation. Involved in a variety
CC       of CNS functions, such as sedation, NREM sleep and PGE2-induced
CC       allodynia, and may have an anti-apoptotic role in
CC       oligodendrocytes. Binds small non-substrate lipophilic molecules,
CC       including biliverdin, bilirubin, retinal, retinoic acid and
CC       thyroid hormone, and may act as a scavenger for harmful
CC       hydrophopic molecules and as a secretory retinoid and thyroid
CC       hormone transporter. Possibly involved in development and
CC       maintenance of the blood-brain, blood-retina, blood-aqueous humor
CC       and blood-testis barrier. It is likely to play important roles in
CC       both maturation and maintenance of the central nervous system and
CC       male reproductive system. {ECO:0000269|PubMed:20667974,
CC       ECO:0000269|PubMed:9475419}.
CC   -!- CATALYTIC ACTIVITY: (5Z,13E,15S)-9-alpha,11-alpha-epidioxy-15-
CC       hydroxyprosta-5,13-dienoate = (5Z,13E,15S)-9-alpha,15-dihydroxy-
CC       11-oxoprosta-5,13-dienoate. {ECO:0000269|PubMed:20667974}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:20667974,
CC       ECO:0000269|Ref.36}.
CC   -!- INTERACTION:
CC       P60409:KRTAP10-7; NbExp=3; IntAct=EBI-948821, EBI-10172290;
CC   -!- SUBCELLULAR LOCATION: Rough endoplasmic reticulum
CC       {ECO:0000269|PubMed:9065498}. Nucleus membrane
CC       {ECO:0000269|PubMed:9065498}. Golgi apparatus
CC       {ECO:0000269|PubMed:9065498}. Cytoplasm, perinuclear region
CC       {ECO:0000269|PubMed:9065498}. Secreted
CC       {ECO:0000269|PubMed:9065498}. Note=Detected on rough endoplasmic
CC       reticulum of arachnoid and menigioma cells. Localized to the
CC       nuclear envelope, Golgi apparatus, secretory vesicles and
CC       spherical cytoplasmic structures in arachnoid trabecular cells,
CC       and to circular cytoplasmic structures in meningeal macrophages
CC       and perivascular microglial cells. In oligodendrocytes, localized
CC       to the rough endoplasmic reticulum and nuclear envelope. In
CC       retinal pigment epithelial cells, localized to distinct
CC       cytoplasmic domains including the perinuclear region. Also
CC       secreted.
CC   -!- TISSUE SPECIFICITY: Abundant in the brain and CNS, where it is
CC       expressed in tissues of the blood-brain barrier and secreted into
CC       the cerebro-spinal fluid. Abundantly expressed in the heart. In
CC       the male reproductive system, it is expressed in the testis,
CC       epididymis and prostate, and is secreted into the seminal fluid.
CC       Expressed in the eye and secreted into the aqueous humor. Lower
CC       levels detected in various tissue fluids such as serum, normal
CC       urine, ascitic fluid and tear fluid. Also found in a number of
CC       other organs including ovary, fimbriae of the fallopian tubes,
CC       kidney, leukocytes. {ECO:0000269|PubMed:10462696,
CC       ECO:0000269|PubMed:11882588, ECO:0000269|PubMed:7692978,
CC       ECO:0000269|PubMed:8599604, ECO:0000269|PubMed:8761996,
CC       ECO:0000269|PubMed:9065498, ECO:0000269|PubMed:9405674,
CC       ECO:0000269|PubMed:9475419, ECO:0000269|PubMed:9844724}.
CC   -!- DEVELOPMENTAL STAGE: Expression in the amniotic fluid increases
CC       dramatically during weeks 12 to 25 of pregnancy. Levels decrease
CC       slowly after 25 weeks. {ECO:0000269|PubMed:8674187}.
CC   -!- INDUCTION: By IL1B/interleukin-1 beta and thyroid hormone.
CC       Probably induced by dexamethasone, dihydrotestosterone (DHT),
CC       progesterone, retinoic acid and retinal. Repressed by the Notch-
CC       Hes signaling pathway. {ECO:0000269|PubMed:9162076}.
CC   -!- DOMAIN: Forms a beta-barrel structure that accommodates
CC       hydrophobic ligands in its interior.
CC       {ECO:0000269|PubMed:20667974}.
CC   -!- PTM: N- and O-glycosylated. Both N-glycosylation recognition sites
CC       are almost quantitatively occupied by N-glycans of the biantennary
CC       complex type, with a considerable proportion of structures bearing
CC       a bisecting GlcNAc. N-glycan at Asn-78: dHex1Hex5HexNAc4. Agalacto
CC       structure as well as sialylated and nonsialylated oligosaccharides
CC       bearing alpha2-3- and/or alpha2-6-linked NeuNAc are present.
CC       {ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:19139490,
CC       ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:19838169,
CC       ECO:0000269|PubMed:22171320, ECO:0000269|PubMed:23234360,
CC       ECO:0000269|PubMed:7692978, ECO:0000269|PubMed:8336134}.
CC   -!- MISCELLANEOUS: It has been proposed that the urinary and serum
CC       levels may provide a sensitive indicator of renal damage in
CC       diabetes mellitus and hypertension. Elevated levels in the
CC       coronary circulation may also be associated with angina. Changes
CC       in charge and molecular weight microheterogeneity, due to
CC       modification of the N-linked oligosaccharides, may be associated
CC       with neurodegenerative disease and multiple sclerosis. Detected in
CC       meningioma but not in other brain tumors and may be considered a
CC       specific cell marker for meningioma. Expression levels in amniotic
CC       fluid are altered in abnormal pregnancies. Levels are lower in
CC       pregnancies with trisomic fetuses and fetuses with renal
CC       abnormalities.
CC   -!- SIMILARITY: Belongs to the calycin superfamily. Lipocalin family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/ptgds/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M61900; AAA36494.2; -; mRNA.
DR   EMBL; M98538; AAB51074.1; -; Genomic_DNA.
DR   EMBL; M98537; AAB51074.1; JOINED; Genomic_DNA.
DR   EMBL; AY026356; AAK07679.1; -; mRNA.
DR   EMBL; DQ297141; ABB84464.1; -; Genomic_DNA.
DR   EMBL; AK312817; BAG35674.1; -; mRNA.
DR   EMBL; AK075333; BAG52113.1; -; mRNA.
DR   EMBL; AL807752; CAI12758.1; -; Genomic_DNA.
DR   EMBL; CH471090; EAW88321.1; -; Genomic_DNA.
DR   EMBL; BC005939; AAH05939.1; -; mRNA.
DR   EMBL; BT019921; AAV38724.1; -; mRNA.
DR   EMBL; BT019922; AAV38725.1; -; mRNA.
DR   CCDS; CCDS7019.1; -.
DR   PIR; A44455; A44455.
DR   PIR; PH1567; PH1567.
DR   RefSeq; NP_000945.3; NM_000954.5.
DR   UniGene; Hs.446429; -.
DR   PDB; 2WWP; X-ray; 2.00 A; A/B=23-190.
DR   PDB; 3O19; X-ray; 1.66 A; A=29-190.
DR   PDB; 3O22; X-ray; 1.40 A; A=29-190.
DR   PDB; 3O2Y; X-ray; 1.70 A; A/B=29-190.
DR   PDB; 4IMN; X-ray; 2.09 A; A=23-190.
DR   PDB; 4IMO; X-ray; 1.88 A; A=23-190.
DR   PDB; 4ORR; X-ray; 1.40 A; A=1-190.
DR   PDB; 4ORS; X-ray; 1.40 A; A/B=1-190.
DR   PDB; 4ORU; X-ray; 1.55 A; A/B=1-190.
DR   PDB; 4ORW; X-ray; 1.66 A; A/B=1-190.
DR   PDB; 4ORX; X-ray; 1.60 A; A/B=1-190.
DR   PDB; 4ORY; X-ray; 1.80 A; A/B/C/D/E/F/G/H=1-190.
DR   PDB; 4OS0; X-ray; 1.75 A; A/B=1-190.
DR   PDB; 4OS3; X-ray; 1.40 A; A/B=1-190.
DR   PDB; 4OS8; X-ray; 1.69 A; A/B=1-190.
DR   PDB; 5WY9; X-ray; 1.45 A; A=23-190.
DR   PDBsum; 2WWP; -.
DR   PDBsum; 3O19; -.
DR   PDBsum; 3O22; -.
DR   PDBsum; 3O2Y; -.
DR   PDBsum; 4IMN; -.
DR   PDBsum; 4IMO; -.
DR   PDBsum; 4ORR; -.
DR   PDBsum; 4ORS; -.
DR   PDBsum; 4ORU; -.
DR   PDBsum; 4ORW; -.
DR   PDBsum; 4ORX; -.
DR   PDBsum; 4ORY; -.
DR   PDBsum; 4OS0; -.
DR   PDBsum; 4OS3; -.
DR   PDBsum; 4OS8; -.
DR   PDBsum; 5WY9; -.
DR   ProteinModelPortal; P41222; -.
DR   SMR; P41222; -.
DR   BioGrid; 111702; 20.
DR   IntAct; P41222; 16.
DR   MINT; MINT-2862256; -.
DR   STRING; 9606.ENSP00000360687; -.
DR   BindingDB; P41222; -.
DR   ChEMBL; CHEMBL3430865; -.
DR   SwissLipids; SLP:000000141; -.
DR   iPTMnet; P41222; -.
DR   PhosphoSitePlus; P41222; -.
DR   UniCarbKB; P41222; -.
DR   BioMuta; PTGDS; -.
DR   DMDM; 730305; -.
DR   UCD-2DPAGE; P41222; -.
DR   PaxDb; P41222; -.
DR   PeptideAtlas; P41222; -.
DR   PRIDE; P41222; -.
DR   DNASU; 5730; -.
DR   Ensembl; ENST00000371625; ENSP00000360687; ENSG00000107317.
DR   Ensembl; ENST00000471521; ENSP00000435033; ENSG00000107317.
DR   GeneID; 5730; -.
DR   KEGG; hsa:5730; -.
DR   UCSC; uc004cke.4; human.
DR   CTD; 5730; -.
DR   DisGeNET; 5730; -.
DR   GeneCards; PTGDS; -.
DR   HGNC; HGNC:9592; PTGDS.
DR   HPA; CAB009916; -.
DR   HPA; HPA004938; -.
DR   MalaCards; PTGDS; -.
DR   MIM; 176803; gene.
DR   neXtProt; NX_P41222; -.
DR   OpenTargets; ENSG00000107317; -.
DR   PharmGKB; PA33945; -.
DR   eggNOG; ENOG410II11; Eukaryota.
DR   eggNOG; ENOG4111YRI; LUCA.
DR   GeneTree; ENSGT00620000088005; -.
DR   HOVERGEN; HBG106490; -.
DR   InParanoid; P41222; -.
DR   KO; K01830; -.
DR   OMA; KGPGQDF; -.
DR   PhylomeDB; P41222; -.
DR   TreeFam; TF336103; -.
DR   BioCyc; MetaCyc:HS02989-MONOMER; -.
DR   BRENDA; 5.3.99.2; 2681.
DR   Reactome; R-HSA-2162123; Synthesis of Prostaglandins (PG) and Thromboxanes (TX).
DR   ChiTaRS; PTGDS; human.
DR   EvolutionaryTrace; P41222; -.
DR   GeneWiki; Prostaglandin_D2_synthase; -.
DR   GenomeRNAi; 5730; -.
DR   PRO; PR:P41222; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000107317; -.
DR   CleanEx; HS_PTGDS; -.
DR   ExpressionAtlas; P41222; baseline and differential.
DR   Genevisible; P41222; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005791; C:rough endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005504; F:fatty acid binding; IDA:UniProtKB.
DR   GO; GO:0004667; F:prostaglandin-D synthase activity; IDA:UniProtKB.
DR   GO; GO:0005501; F:retinoid binding; ISS:UniProtKB.
DR   GO; GO:0005215; F:transporter activity; ISS:UniProtKB.
DR   GO; GO:0019371; P:cyclooxygenase pathway; TAS:Reactome.
DR   GO; GO:0001516; P:prostaglandin biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0045187; P:regulation of circadian sleep/wake cycle, sleep; ISS:UniProtKB.
DR   GO; GO:0006810; P:transport; ISS:UniProtKB.
DR   Gene3D; 2.40.128.20; -; 1.
DR   InterPro; IPR012674; Calycin.
DR   InterPro; IPR002345; Lipocalin.
DR   InterPro; IPR022272; Lipocalin_CS.
DR   InterPro; IPR000566; Lipocln_cytosolic_FA-bd_dom.
DR   InterPro; IPR002972; PstgldnD_synth.
DR   Pfam; PF00061; Lipocalin; 1.
DR   PRINTS; PR00179; LIPOCALIN.
DR   PRINTS; PR01254; PGNDSYNTHASE.
DR   SUPFAM; SSF50814; SSF50814; 1.
DR   PROSITE; PS00213; LIPOCALIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Disulfide bond; Endoplasmic reticulum; Fatty acid biosynthesis;
KW   Fatty acid metabolism; Glycoprotein; Golgi apparatus; Isomerase;
KW   Lipid biosynthesis; Lipid metabolism; Membrane; Nucleus; Polymorphism;
KW   Prostaglandin biosynthesis; Prostaglandin metabolism;
KW   Reference proteome; Secreted; Signal; Transport.
FT   SIGNAL        1     22       {ECO:0000269|PubMed:1726844,
FT                                ECO:0000269|PubMed:7689714,
FT                                ECO:0000269|PubMed:7692978,
FT                                ECO:0000269|PubMed:8336134,
FT                                ECO:0000269|PubMed:8336140,
FT                                ECO:0000269|PubMed:9475419,
FT                                ECO:0000269|PubMed:9844724}.
FT   CHAIN        23    190       Prostaglandin-H2 D-isomerase.
FT                                /FTId=PRO_0000017945.
FT   ACT_SITE     65     65       Nucleophile.
FT   CARBOHYD     29     29       O-linked (GalNAc...) serine.
FT                                {ECO:0000269|PubMed:23234360}.
FT   CARBOHYD     51     51       N-linked (GlcNAc...) (complex)
FT                                asparagine. {ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19838169,
FT                                ECO:0000269|PubMed:8336134}.
FT   CARBOHYD     78     78       N-linked (GlcNAc...) (complex)
FT                                asparagine. {ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19139490,
FT                                ECO:0000269|PubMed:19838169,
FT                                ECO:0000269|PubMed:22171320,
FT                                ECO:0000269|PubMed:8336134}.
FT   DISULFID     89    186       {ECO:0000250}.
FT   VARIANT      56     56       R -> Q (in dbSNP:rs11552179).
FT                                /FTId=VAR_004273.
FT   MUTAGEN      59     59       K->A: Increases enzyme activity about
FT                                two-fold. {ECO:0000269|PubMed:20667974}.
FT   MUTAGEN      64     64       M->A: Reduces enzyme activity almost ten-
FT                                fold. {ECO:0000269|PubMed:20667974}.
FT   MUTAGEN      65     65       C->A: Loss of enzyme activity.
FT                                {ECO:0000269|PubMed:20667974}.
FT   MUTAGEN      79     79       L->A: Reduces enzyme activity over ten-
FT                                fold. {ECO:0000269|PubMed:20667974}.
FT   MUTAGEN      83     83       F->A: Reduces enzyme activity about five-
FT                                fold. {ECO:0000269|PubMed:20667974}.
FT   MUTAGEN     131    131       L->A: Reduces enzyme activity almost ten-
FT                                fold. {ECO:0000269|PubMed:20667974}.
FT   MUTAGEN     149    149       Y->A: Increases enzyme activity about
FT                                two-fold. {ECO:0000269|PubMed:20667974}.
FT   CONFLICT     25     25       E -> P (in Ref. 18; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     33     33       N -> L (in Ref. 17; AA sequence).
FT                                {ECO:0000305}.
FT   HELIX        36     39       {ECO:0000244|PDB:3O22}.
FT   STRAND       41     51       {ECO:0000244|PDB:3O22}.
FT   HELIX        53     60       {ECO:0000244|PDB:3O22}.
FT   STRAND       62     71       {ECO:0000244|PDB:3O22}.
FT   STRAND       75     85       {ECO:0000244|PDB:3O22}.
FT   STRAND       88     98       {ECO:0000244|PDB:3O22}.
FT   STRAND      104    108       {ECO:0000244|PDB:3O22}.
FT   TURN        110    112       {ECO:0000244|PDB:4ORR}.
FT   STRAND      115    123       {ECO:0000244|PDB:3O22}.
FT   STRAND      125    138       {ECO:0000244|PDB:3O22}.
FT   HELIX       139    142       {ECO:0000244|PDB:3O22}.
FT   STRAND      144    154       {ECO:0000244|PDB:3O22}.
FT   HELIX       157    169       {ECO:0000244|PDB:3O22}.
FT   HELIX       174    176       {ECO:0000244|PDB:3O22}.
FT   STRAND      177    179       {ECO:0000244|PDB:3O22}.
FT   STRAND      184    186       {ECO:0000244|PDB:3O22}.
SQ   SEQUENCE   190 AA;  21029 MW;  DF35FE48AD0D5EF3 CRC64;
     MATHHTLWMG LALLGVLGDL QAAPEAQVSV QPNFQQDKFL GRWFSAGLAS NSSWLREKKA
     ALSMCKSVVA PATDGGLNLT STFLRKNQCE TRTMLLQPAG SLGSYSYRSP HWGSTYSVSV
     VETDYDQYAL LYSQGSKGPG EDFRMATLYS RTQTPRAELK EKFTAFCKAQ GFTEDTIVFL
     PQTDKCMTEQ
//
